More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...
The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss ...
American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...
The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
You might think that an intense burst of exercise would only make you more ravenous and reaching for piles of hot buttered ...
Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results